Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Is a |
Cilastatin- and imipenem-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Substance with beta-lactam structure and antibacterial mechanism of action (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Carbapenem |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Cilastatin |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Imipenem |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bactericide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has manufactured dose form |
Injection (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Is a |
Product manufactured as parenteral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has manufactured dose form |
Powder for solution for injection |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Is a |
Cilastatin- and imipenem-containing product in parenteral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has precise active ingredient |
Cilastatin sodium (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has presentation strength numerator value |
250 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has presentation strength numerator value |
250 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has precise active ingredient |
Imipenem |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
Imipenem anhydrous (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
Cilastatin |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
Vial (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
Vial (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has unit of presentation |
Vial (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Count of base of active ingredient |
deux |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Is a |
Product containing only cilastatin and imipenem in parenteral dose form (medicinal product form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Plays role |
Antibacterial therapeutic role (role) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|